세계의 유방 병변 국소화 시장 : 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별, 지역별, 경쟁별(2020-2030년)

Global breast lesion localization methods market was valued at USD 764.26 million in 2024 and is projected to reach USD 1,073.78 million by 2030, growing at a compound annual growth rate (CAGR) of 6.03% during the forecast period. This market is witnessing robust growth, driven by the rising global incidence of breast cancer and the increasing demand for accurate diagnostic and surgical intervention methods.

Breast lesion localization techniques play a critical role in enabling radiologists and surgeons to accurately identify and remove abnormal tissue during breast-conserving surgeries or biopsies. These methods are vital for preserving healthy tissue while ensuring the effective treatment of malignant or suspicious lesions.

One of the principal growth drivers is the heightened awareness of early breast cancer detection, supported by the widespread implementation of screening programs. As breast cancer continues to be one of the most prevalent cancers among women worldwide, early diagnosis is essential to improving survival rates and treatment outcomes. Consequently, there is a growing emphasis on developing advanced and highly reliable localization techniques that enhance surgical precision, minimize the risk of reoperation, and improve overall clinical success.

However, market expansion may be hindered by the high cost of advanced localization technologies and the need for specialized training. These factors pose barriers, particularly in low- and middle-income countries. In addition, regulatory complexities and inconsistent reimbursement frameworks across regions may limit adoption in certain markets.

Key Market Drivers

Expansion of the Global Healthcare Sector

The continued growth of the global healthcare industry is a major catalyst for the breast lesion localization methods market. Global healthcare expenditures now exceed USD 4 trillion annually, with pharmaceuticals and biotechnology accounting for approximately USD 850 billion, and medical technology and diagnostics contributing more than USD 400 billion. With rapid advancements in medical technologies and a stronger focus on early cancer detection, healthcare systems are increasingly investing in sophisticated localization solutions.

These technologies are especially critical for detecting and removing non-palpable breast lesions, ensuring more accurate surgical interventions. The growing incidence of breast cancer is a significant factor supporting this trend. According to the World Health Organization (WHO), breast cancer was responsible for 670,000 deaths globally in 2022. Notably, nearly half of all diagnosed cases occur in women without known risk factors other than age and gender. Additionally, approximately 0.5-1% of breast cancer cases are diagnosed in men.

As healthcare providers enhance screening initiatives and early detection strategies, there is a corresponding increase in the identification of breast lesions requiring pre-surgical localization. Advanced techniques such as wire-guided localization (WGL), radioactive seed localization (RSL), and magnetic seed localization are becoming essential tools in ensuring surgical accuracy and reducing the likelihood of complications or repeat procedures.

Key Market Challenges

Limited Accessibility in Developing Markets

One of the key obstacles facing the breast lesion localization methods market is the restricted availability of advanced technologies in developing regions. While high-income countries have made substantial progress in breast cancer screening and diagnostic infrastructure, many low- and middle-income regions continue to face limited access to modern localization methods.

This disparity impacts the quality of patient care and poses challenges to early diagnosis and effective treatment. Contributing factors include inadequate healthcare infrastructure, limited access to advanced equipment, and a shortage of trained professionals. Many facilities in these regions still rely on traditional methods, such as wire localization, which, while functional, offer lower precision and carry a higher risk of surgical complications and reoperations.

Key Market Trends

Emphasis on Early Detection and Technological Innovation

A prominent trend shaping the breast lesion localization methods market is the increasing prioritization of early breast cancer detection. Digital mammography-recognized for its high specificity and sensitivity (exceeding 90%)-continues to be the cornerstone of breast cancer screening across high-income countries. These efforts are yielding earlier diagnoses and improving survival outcomes.

As global healthcare systems strive to detect cancer at its earliest, most treatable stages, the demand for advanced lesion localization technologies is growing. Early-stage lesions, which are often small and non-palpable, necessitate precise localization to facilitate accurate surgical removal. This requirement is accelerating the adoption of cutting-edge localization techniques, including wire-guided, radioactive seed, and magnetic seed localization.

These technologies are helping redefine breast cancer management by enabling more effective surgical planning, reducing the likelihood of reoperation, and enhancing patient outcomes. As the emphasis on early intervention intensifies, the market is poised to benefit from the increased integration of innovative, image-guided localization methods into clinical workflows.

Key Market Players

• Becton, Dickinson and Company
• SOMATEX Medical Technologies GmbH
• Argon Medical Devices, Inc.
• Merit Medical Systems, Inc.
• Cook Group Incorporated
• STERYLAB S.r.l.
• Theragenics Corporation
• Mdl Srl
• Stryker Corporation

Report Scope

In this report, the Global Breast Lesion Localization Methods Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Breast Lesion Localization Methods Market, By Type:

• Radioisotope Localization
• Radio Guided Occult-Lesion Localization (ROLL)
• Radioactive-Seed Localization (RSL)
• Magnetic Tracer
• Others

Breast Lesion Localization Methods Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Breast Lesion Localization Methods Market.

Available Customizations:

Global Breast Lesion Localization Methods Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Breast Lesion Localization Methods Market

5. Global Breast Lesion Localization Methods Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Radioisotope Localization, Radio Guided Occult-Lesion Localization (ROLL), Radioactive-Seed Localization (RSL), Magnetic Tracer, Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Breast Lesion Localization Methods Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Breast Lesion Localization Methods Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
  • 6.3.2. Mexico Breast Lesion Localization Methods Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
  • 6.3.3. Canada Breast Lesion Localization Methods Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type

7. Europe Breast Lesion Localization Methods Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Breast Lesion Localization Methods Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
  • 7.3.2. Germany Breast Lesion Localization Methods Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
  • 7.3.3. United Kingdom Breast Lesion Localization Methods Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
  • 7.3.4. Italy Breast Lesion Localization Methods Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
  • 7.3.5. Spain Breast Lesion Localization Methods Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type

8. Asia Pacific Breast Lesion Localization Methods Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Breast Lesion Localization Methods Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
  • 8.3.2. India Breast Lesion Localization Methods Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
  • 8.3.3. South Korea Breast Lesion Localization Methods Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
  • 8.3.4. Japan Breast Lesion Localization Methods Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
  • 8.3.5. Australia Breast Lesion Localization Methods Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type

9. South America Breast Lesion Localization Methods Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Breast Lesion Localization Methods Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
  • 9.3.2. Argentina Breast Lesion Localization Methods Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
  • 9.3.3. Colombia Breast Lesion Localization Methods Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type

10. Middle East and Africa Breast Lesion Localization Methods Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Breast Lesion Localization Methods Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
  • 10.3.2. Saudi Arabia Breast Lesion Localization Methods Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
  • 10.3.3. UAE Breast Lesion Localization Methods Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Breast Lesion Localization Methods Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. SOMATEX Medical Technologies GmbH
• 15.3. Argon Medical Devices, Inc.
• 15.4. Merit Medical Systems, Inc.
• 15.5. Cook Group Incorporated
• 15.6. STERYLAB S.r.l.
• 15.7. Theragenics Corporation
• 15.8. Mdl Srl
• 15.9. Stryker Corporation

16. Strategic Recommendations

17. About Us & Disclaimer